Investor Update

Basel, 17 December 2013

Invitation to Roche's Full Year Results for 2013

30 January 2014 – 15:00 GMT – Presentation in London (16:00 CET)

Roche will publish its Full Year Results for 2013 prior to the opening of the Swiss Stock Exchange on 30 January 2014.

7:00 CET / 6:00 GMT / 1:00 AM EST / 10:00 PM PST (evening before)

Release will be e-mailed and posted on the Roche IR website click here.
Presentation slides will be posted on the Roche IR website click here.

We would like to invite all interested parties to participate or dial in to the event outlined below.

30 January 2014, London

The Full Year Presentation followed by Q&A and additional break-out sessions will be held at the May Fair Hotel, London

Presenters:

  • Severin Schwan, CEO Roche Group
  • Alan Hippe, Chief Financial and IT Officer
  • Daniel O'Day, COO Pharmaceuticals
  • Roland Diggelmann, COO Diagnostics

Meeting information

Download to my calendar

Date: 30 January 2014
Time (GMT):14:30 Registration
15:00 Meeting starts
18:00 Meeting ends

Following the event we would also like to invite you to drinks and canapés to give you the opportunity to speak to management more informally.

Venue: The May Fair Hotel, The Crystal Room Entrance, Berkeley Street, London W1J 8LT
map

To register for the event, please follow the link

This presentation can also be accessed through a live video webcast:
http://ir.roche.com.

Break-out sessions covering the topics Strategy, Finance & Accounting, Pharmaceuticals and Diagnostics will be held following the main Q&A.

Alternatively, you may dial in to the conference, using the following dial-in numbers (listen-only mode, no live-access to speakers), 10-15 minutes prior to the scheduled start:

+41 (0) 58 310 5000 (Europe and ROW) or
+44 (0) 203 059 5862 (UK) or
+1 (1) 631 570 5613 (USA)

To expedite the registration process on the day of the conference call, you may pre-register for the event. click here.

Replay

A replay will be available one hour after each event, for 48 hours and can be accessed by dialing:

+41 (0) 91 612 4330 (Europe and ROW) or
+44 (0) 207 108 6233 (UK) or
+1 (1) 866 416 2558 (USA)

Please enter the conference ID 18097 followed by the # sign.

A replay of the webcast will be available on demand on the Roche website. click here.